01/05/2025

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

01/05/2025

May 1, 2025, 17:54 | Drugs
Zongertinib breakthrough: Elizabeth McKenna highlights new study on HER2-driven cancers
Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X about a recent…
May 1, 2025, 17:49 | Insight
Miguel Bronchud shared insights on the tumor microenvironment in cancer progression
Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions, shared a post on LinkedIn:…
May 1, 2025, 17:39 | Opinion
Daniel Flora: Letter to my new cancer patients - What I want you to know as we begin this journey
Daniel Flora, Medical Director, Oncology Research and Hematologist/Oncologist at St. Elizabeth Healthcare. Breast cancer, shared…
May 1, 2025, 17:30 | Insight
Gustavo Viani: Supercharged Spinal Metastases SBRT-SIB Boost Scores High Local Control 
Gustavo Viani, Associate Professor at Faculty of Medicine of Ribeirão Preto (FMRP), University of São…
May 1, 2025, 17:29 | Blog
Muhammad Shaalan Beg shared methods to reimagine patient-centric clinical trials at AACR25 - Moffitt Cancer Center
Moffitt Cancer Center, shared a post on X: "In the final session of the AACR25…
May 1, 2025, 17:15 | Blog
Shaban Juma Shares Vital Insights on Lung Cancer and Its Primary Risk Factors - Cancer Fight Tanzania
Cancer Fight Tanzania shared a post on LinkedIn: "Smoking is the leading cause of lung…
May 1, 2025, 17:14 | Drugs
Ana Velázquez Mañana highlights NEJM study by John Heymach on Zongertinib’s efficacy in HER2-Mutant NSCLC at AACR25
Ana Velázquez Mañana, shared a post on X, about a recent article by John Heymach et…
May 1, 2025, 17:09 | Blog
Aynur Aktas: Our Abstract Has Been Selected for Oral Presentation at MASCC 2025
Aynur Aktas, Research Scientist at Atrium Health, shared a post on LinkedIn: "I am delighted…
May 1, 2025, 17:01 | Insight
Ken Cardona leads EA7211/STRASS 2 clinical trial: A randomized study in retroperitoneal sarcoma - ECOG-ACRIN Cancer Research Group
ECOG-ACRIN Cancer Research Group, shared a post on X: "Clinical Trial EA7211/STRASS 2, led in…
May 1, 2025, 16:54 | Blog
Phnom Penh Launches Cancer Care Projects to Strengthen Services - City Cancer Challenge
City Cancer Challenge shared a post on LinkedIn: "In an event that brought together hospital…
All: 87 Posts: 11 - 20
Special Coverage